Posted by Michael Wonder on 29 Oct 2015
TGA publishes AusPAR for Harvoni
29 October 2015 - The TGA approved Harvoni for the treatment of chronic hepatitis genotype 1 infection in adults on 8 May 2015.
For more details, go to: http://www.tga.gov.au/auspar/auspar-ledipasvir-sofosbuvir
